Neuro-inflammatory risk factors for treatment failure in “early second stage” sleeping sickness patients treated with Pentamidine
- 1 November 2003
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 144 (1-2) , 132-138
- https://doi.org/10.1016/j.jneuroim.2003.08.033
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: